机译：Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial
Italian Natl Res Ctr Aging IRCCS INRCA Geriatr &, Ancona, Italy;
Univ East Anglia, Fac Med & Hlth Sci, Norwich, Norfolk, England;
Natl Univ Ireland, Univ Coll Cork, Clin Res Facil, Cork, IrelandUniv Coll Cork, Cork Univ Hosp Grp, Sch Med, Med Cork Ireland, Cork, IrelandLandspitali Univ Hosp Reykjavik, Landspitali, IcelandUniv Aberdeen, Inst Appl Hlth Sci Ageing Clin & Expt Res, NHS Grampian, Aberdeen, ScotlandUniv Ghent Med, Univ Hosp Ghent, Ghent, BelgiumHosp Univ Ramon y Cajal Geriatr, Madrid, SpainUniv Coll Cork, Sch Pharm, Cork, IrelandUniv Coll Cork, Cork, IrelandCork Univ Hosp Geriatr Med, Cork, IrelandUniv Coll Cork, Sch Med Geriatr, Cork, IrelandNatl Univ Ireland, Univ Coll Cork, Sch Pharm, Pharmaceut Care Res Grp, Cork, IrelandRoyal Coll Surg, Sch Pharm, Dublin, IrelandUniv Coll Cork, Clin Res Facil, Cork, IrelandUniv Coll Cork, Sch Epidemiol & Publ Hlth, Cork, IrelandLandspitali Univ Hosp, Geriatr Med Reykjavik, Landspitali, IcelandAberdeen Royal Infirm, NHS Grampian, Aberdeen, ScotlandUniv Hosp Ghent, Ghent, Belgium;
adverse drug reactions; older people; multi-morbidity; polypharmacy; prevention; STOPP/START criteria; software;
